Synapse - Genitourinary Oncology Service

Results (5695)

Next-generation sequencing reveals genomic determinants of long-term response to mTOR inhibitors in patients with advanced RCC

Meeting Abstract

Voss, M. H.; Hakimi, A. A.; Brannon, A. R.; Scott, S.; Takeda, S.; Liu, H.; Chen, Y.; Motzer, R. J.; Berger, M. F.; Hsieh, J. J.
BJU International (2012)

Fulltext@MSK | Save

Tivozanib pharmacokinetic (PK)/pharmacodynamic (PD) analysis of blood pressure and soluble vascular endothelial growth factor receptor 2 (sVEGFR2) in patients with advanced renal cell carcinoma (RCC)

Meeting Abstract

Nosov, D. A.; Motzer, R. J.; Loewy, J.; Hodge, L.; Esteves, B.; Berkenblit, A.; Yin, W.; Dykstra, K.; Hutson, T. E.; Cotreau, M. M.
BJU International (2012)

Fulltext@MSK | Save

Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a Phase III randomized, open-label, multicenter trial

Meeting Abstract

Motzer, R.; Nosov, D.; Eisen, T.; Bondarenko, I.; Lesovoy, V.; Lipatov, O.; Tomczak, P.; Lyulko, O.; Alyasova, A.; Harza, M.; more...
BJU International (2012)

Fulltext@MSK | Save

Tumor suppressor screens of 3p chromatin modulators link BAP1 mutations to poor clinical outcomes in clear cell renal cell carcinoma

Meeting Abstract

Hakimi, A. A.; Chen, Y. B.; Wren, J.; Ostrovnaya, I.; Gonen, M.; Abdel-Wahab, O.; Heguy, A.; Liu, H.; Takeda, S.; Tickoo, S. K.; more...
BJU International (2012)

Fulltext@MSK | Save

Detailed comparison of the safety of tivozanib versus sorafenib in patients with advanced/metastatic renal cell carcinoma (mRCC) from a Phase III trial

Meeting Abstract

Eisen, T.; Sternberg, C. N.; Tomczak, P.; Harza, M.; Jinga, V.; Esteves, B.; Motzer, R.
BJU International (2012)

Fulltext@MSK | Save

Open-label phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Agarwala, S. S.; Wang, J.; Ye, D.; Sallo, V.; Stergiopoulos, S. G.; Brechenmacher, T.; Motzer, R. J.
BJU International (2012)

Fulltext@MSK | Save

Disruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice

Journal Article

Xiong, X.; Chorzalska, A.; Dubielecka, P. M.; White, J. R.; Vedvyas, Y.; Hedvat, C. V.; Haimovitz-Friedman, A.; Koutcher, J. A.; Reimand, J.; Bader, G. D.; more...
Oncogenesis (2012)

Fulltext@MSK | Save

Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo

Journal Article

Sun, X.; Xing, L.; Deng, X.; Hsiao, H. T.; Minami, A.; Koutcher, J. A.; Clifton Ling, C.; Li, G. C.
Radiotherapy and Oncology (2012)

Fulltext@MSK | Save

Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial

Journal Article

Stein, A.; Wang, W.; Carter, A. A.; Chiparus, O.; Hollaender, N.; Kim, H.; Motzer, R. J.; Sarr, C.
BMC Cancer (2012)

Fulltext@MSK | Save

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: A prospective study

Journal Article

Ross, R. W.; Galsky, M. D.; Scher, H. I.; Magidson, J.; Magidson, K.; Lee, G. S. M.; Katz, L.; Subudhi, S. K.; Anand, A.; Fleisher, M.; more...
Lancet Oncology (2012)

Fulltext@MSK | Save